Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
89.50
+1.82 (2.08%)
At close: Feb 21, 2025, 4:00 PM
89.34
-0.16 (-0.18%)
After-hours: Feb 21, 2025, 7:53 PM EST
Merck & Co. Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Revenue | 64,168 | 60,115 | 59,283 | 48,704 | 41,518 | Upgrade
|
Revenue Growth (YoY) | 6.74% | 1.40% | 21.72% | 17.31% | 6.13% | Upgrade
|
Cost of Revenue | 12,289 | 15,915 | 17,206 | 13,466 | 11,990 | Upgrade
|
Gross Profit | 51,879 | 44,200 | 42,077 | 35,238 | 29,528 | Upgrade
|
Selling, General & Admin | 11,249 | 9,884 | 9,669 | 9,403 | 8,569 | Upgrade
|
Research & Development | 17,865 | 18,342 | 11,918 | 11,942 | 10,564 | Upgrade
|
Operating Expenses | 29,114 | 28,226 | 21,587 | 21,345 | 19,133 | Upgrade
|
Operating Income | 22,765 | 15,974 | 20,490 | 13,893 | 10,395 | Upgrade
|
Interest Expense | -1,271 | -1,146 | -962 | -806 | -831 | Upgrade
|
Interest & Investment Income | 415 | 365 | 157 | 36 | 118 | Upgrade
|
Currency Exchange Gain (Loss) | -227 | -370 | -237 | -297 | -145 | Upgrade
|
Other Non Operating Income (Expenses) | 1,647 | 420 | 681 | 256 | 71 | Upgrade
|
EBT Excluding Unusual Items | 23,329 | 15,243 | 20,129 | 13,082 | 9,608 | Upgrade
|
Merger & Restructuring Charges | -888 | -12,342 | -666 | -868 | -4,993 | Upgrade
|
Gain (Loss) on Sale of Investments | 14 | 340 | -1,419 | 1,940 | 1,338 | Upgrade
|
Asset Writedown | - | -779 | -1,600 | -275 | -90 | Upgrade
|
Legal Settlements | - | -573 | - | - | - | Upgrade
|
Other Unusual Items | -2,519 | - | - | - | - | Upgrade
|
Pretax Income | 19,936 | 1,889 | 16,444 | 13,879 | 5,863 | Upgrade
|
Income Tax Expense | 2,803 | 1,512 | 1,918 | 1,521 | 1,340 | Upgrade
|
Earnings From Continuing Operations | 17,133 | 377 | 14,526 | 12,358 | 4,523 | Upgrade
|
Earnings From Discontinued Operations | - | - | - | 704 | 2,548 | Upgrade
|
Net Income to Company | 17,133 | 377 | 14,526 | 13,062 | 7,071 | Upgrade
|
Minority Interest in Earnings | -16 | -12 | -7 | -13 | -4 | Upgrade
|
Net Income | 17,117 | 365 | 14,519 | 13,049 | 7,067 | Upgrade
|
Net Income to Common | 17,117 | 365 | 14,519 | 13,049 | 7,067 | Upgrade
|
Net Income Growth | 4589.59% | -97.49% | 11.27% | 84.65% | -28.20% | Upgrade
|
Shares Outstanding (Basic) | 2,541 | 2,537 | 2,532 | 2,530 | 2,530 | Upgrade
|
Shares Outstanding (Diluted) | 2,541 | 2,547 | 2,542 | 2,538 | 2,541 | Upgrade
|
Shares Change (YoY) | -0.24% | 0.20% | 0.16% | -0.12% | -1.51% | Upgrade
|
EPS (Basic) | 6.74 | 0.14 | 5.73 | 5.16 | 2.79 | Upgrade
|
EPS (Diluted) | 6.74 | 0.14 | 5.71 | 5.14 | 2.78 | Upgrade
|
EPS Growth | 4711.66% | -97.55% | 11.15% | 84.62% | -27.15% | Upgrade
|
Free Cash Flow | - | 9,143 | 14,707 | 9,661 | 5,812 | Upgrade
|
Free Cash Flow Per Share | - | 3.59 | 5.79 | 3.81 | 2.29 | Upgrade
|
Dividend Per Share | 3.080 | 2.920 | 2.760 | 2.600 | 2.440 | Upgrade
|
Dividend Growth | 5.48% | 5.80% | 6.15% | 6.56% | 10.91% | Upgrade
|
Gross Margin | 80.85% | 73.53% | 70.98% | 72.35% | 71.12% | Upgrade
|
Operating Margin | 35.48% | 26.57% | 34.56% | 28.53% | 25.04% | Upgrade
|
Profit Margin | 26.68% | 0.61% | 24.49% | 26.79% | 17.02% | Upgrade
|
Free Cash Flow Margin | - | 15.21% | 24.81% | 19.84% | 14.00% | Upgrade
|
EBITDA | 26,940 | 19,706 | 24,279 | 17,016 | 13,613 | Upgrade
|
EBITDA Margin | 41.98% | 32.78% | 40.95% | 34.94% | 32.79% | Upgrade
|
D&A For EBITDA | 4,175 | 3,732 | 3,789 | 3,123 | 3,218 | Upgrade
|
EBIT | 22,765 | 15,974 | 20,490 | 13,893 | 10,395 | Upgrade
|
EBIT Margin | 35.48% | 26.57% | 34.56% | 28.53% | 25.04% | Upgrade
|
Effective Tax Rate | 14.06% | 80.04% | 11.66% | 10.96% | 22.86% | Upgrade
|
Advertising Expenses | - | 2,300 | 2,200 | 2,000 | 1,800 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.